Английская Википедия:Etynodiol diacetate

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Cs1 config Шаблон:Infobox drug

Etynodiol diacetate, or ethynodiol diacetate, sold under the brand name Ovulen among others, is a progestin medication which is used in birth control pills.[1][2][3] The medication is available only in combination with an estrogen.[4] It is taken by mouth.[5]

Etynodiol diacetate is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone.[6][7] It has weak androgenic and estrogenic activity and no other important hormonal activity.[8][9][10] The medication is a prodrug of norethisterone in the body, with etynodiol occurring as an intermediate.[6][7][11]

Etynodiol, a related compound, was discovered in 1954, and etynodiol diacetate was introduced for medical use in 1965.[12][13] The combination ethynodiol with mestranol (Ovulen) was approved for medical use in the United States in 1966.[14] The combination ethinylestradiol with ethynodiol (Demulen) was approved for medical use in the United States in 1970.[15]

In 2021, the combination with ethinylestradiol was the 276th most commonly prescribed medication in the United States, with more than 800,000 prescriptions.[16][17]

Medical uses

Etynodiol diacetate is used in combination with an estrogen such as ethinylestradiol or mestranol in combined oral contraceptives for women for the prevention of pregnancy.[5]

Side effects

Шаблон:See also

Pharmacology

Файл:Norethisterone.svg
Norethisterone (3-ketoetynodiol), the active metabolite of etynodiol diacetate.

Etynodiol diacetate is virtually inactive in terms of affinity for the progesterone and androgen receptors and acts as a rapidly converted prodrug of norethisterone, with etynodiol occurring as an intermediate.[6][7][11] Upon oral administration and during first-pass metabolism in the liver, etynodiol diacetate is rapidly converted by esterases into etynodiol,[11] which is followed by oxygenation of the C3 hydroxyl group to produce norethisterone.[7] In addition to its progestogenic activity, etynodiol diacetate has weak androgenic activity,[8][9] and, unlike most progestins but similarly to norethisterone and noretynodrel,[18] also has some estrogenic activity.[9][10]

The pharmacokinetics of etynodiol diacetate have been reviewed.[19]

Шаблон:Relative affinities of norethisterone, metabolites, and prodrugs

Chemistry

Шаблон:See also

Etynodiol diacetate, also known as 3β-hydroxy-17α-ethynyl-19-nortestosterone 3β,17β-diaceate, 3β-hydroxynorethisterone 3β,17β-diacetate, or 17α-ethynylestr-4-ene-3β,17β-diol 3β,17β-diacetate, is a synthetic estrane steroid and a derivative of testosterone.[20][2][3] It is specifically a derivative of 19-nortestosterone and 17α-ethynyltestosterone, or of norethisterone (17α-ethynyl-19-nortestosterone), in which the C3 ketone group has been dehydrogenated into a C3β hydroxyl group and acetate esters have been attached at the C3β and C17β positions.[2][3] Etynodiol diacetate is the 3β,17β-diacetate ester of etynodiol (17α-ethynylestr-4-ene-3β,17β-diol).[2][3]

Synthesis

Файл:Ethynodiol diacetate synthesis.svg
Ethynodiol diacetate synthesis:[21] F. B. Colton, Шаблон:US patent (1958 to Searle). Prepn of the 3-acetate, 17-acetate, and diacetate: P. D. Klimstra, Шаблон:US patent (1965 to Searle); see also:[22]

Chemical syntheses of etynodiol diacetate have been published.[19]

Reduction of norethisterone (1) affords the 3,17-diol. The 3β-hydroxy compound is the desired product; since reactions at C3 do not show nearly the stereoselectivity as those at C17 by virtue of the relative lack of stereo-directing proximate substituents, the formation of the desired isomer is engendered by use of a bulky reducing agent, lithium tri-tert-butoxyaluminum hydride. Acetylation of the 3β,17β-diol affords etynodiol diacetate (3).[21]

History

Etynodiol was first synthesized in 1954, via reduction of norethisterone, and etynodiol diacetate was introduced for medical use in 1965.[12][13]

Society and culture

Generic names

Etynodiol diacetate is the generic name of the drug (the Шаблон:Abbrlink of its free alcohol form is etynodiol), while ethynodiol diacetate is its Шаблон:Abbrlink, Шаблон:Abbrlink, and Шаблон:Abbrlink.[2][3][4] It is also known by its former developmental code names CB-8080 and SC-11800.[2][3][4]

Brand names

Etynodiol diacetate is or has been marketed under brand names including Conova, Continuin, Demulen,[15][23] Femulen, Kelnor,[24][23] Lo-Malmorede,[25] Luteonorm, Luto-Metrodiol, Malmorede,[26] Metrodiol, Ovulen,[14][23] Soluna, Zovia,[27] and others.[2][3][4]

Availability

Etynodiol diacetate is marketed in only a few countries, including the United States, Canada, Argentina, and Oman.[4]

References

Шаблон:Reflist

Шаблон:Navboxes Шаблон:Navboxes Шаблон:Portal bar Шаблон:Authority control

  1. Шаблон:Cite book
  2. 2,0 2,1 2,2 2,3 2,4 2,5 2,6 Шаблон:Cite book
  3. 3,0 3,1 3,2 3,3 3,4 3,5 3,6 Шаблон:Cite book
  4. 4,0 4,1 4,2 4,3 4,4 Шаблон:Cite web
  5. 5,0 5,1 Шаблон:Cite book
  6. 6,0 6,1 6,2 Шаблон:Cite journal
  7. 7,0 7,1 7,2 7,3 Шаблон:Cite book
  8. 8,0 8,1 Шаблон:Cite book
  9. 9,0 9,1 9,2 Шаблон:Cite book
  10. 10,0 10,1 Шаблон:Cite book
  11. 11,0 11,1 11,2 Шаблон:Cite journal
  12. 12,0 12,1 Шаблон:Cite journal
  13. 13,0 13,1 Шаблон:Cite book
  14. 14,0 14,1 Шаблон:Cite web
  15. 15,0 15,1 Шаблон:Cite web
  16. Шаблон:Cite web
  17. Шаблон:Cite web
  18. Шаблон:Cite book
  19. 19,0 19,1 Шаблон:Cite book
  20. Ошибка цитирования Неверный тег <ref>; для сносок SchindlerCampagnoli2003 не указан текст
  21. 21,0 21,1 Шаблон:Cite journal
  22. Шаблон:Cite journal
  23. 23,0 23,1 23,2 Шаблон:Cite web
  24. Ошибка цитирования Неверный тег <ref>; для сносок Kelnor FDA label не указан текст
  25. Шаблон:Cite web
  26. Шаблон:Cite web
  27. Ошибка цитирования Неверный тег <ref>; для сносок Zovia FDA label не указан текст